Serum levels and elimination of thiamphenicol in patients with impaired liver function and with renal failure on dialysis
Oldershausen, H.F.; Menz, H.P.; Hartmann, I.; Bezler, H.J.; Ilg, R.; Burck, G.C.
Postgraduate Medical Journal 50(Suppl 5): 44-46
1974
ISSN/ISBN: 0032-5473 PMID: 4470818 Document Number: 77182
Document emailed within 1 workday
Related Documents
Saran, R.; Goel, S.; Stack, A.; Prowant, B.; Moore, H.; Nolph, K.D.; Khanna, R. 2001: Serum insulin-like growth factor i levels do not correlate with residual renal function in dialysis patients Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 21(5): 522-525Spring, P.; Räber, J.; Reber, H.; Dettli, L. 1973: Elimination of the antibiotic cephacetril in patients with impaired renal function Schweizerische Medizinische Wochenschrift 103(21): 783-788
Spring, P.; Räber, J.; Reber, H.; Dettli, L. 1974: The elimination of the antibiotic cephacetrile in patients with impaired renal function Arzneimittel-Forschung 24(9b): 1462-1466
Traeger, J.; Moskovchenko, J.; Monier, J.C.; Zech, P. 1974: Changes in blood thiamphenicol levels in renal failure Postgraduate Medical Journal 50 Suppl. 5: 39-40
Nakayama, M.; Tanno, Y.; Otsuka, Y.; Takahashi, H.; Ikeda, M.; Katoh, N.; Yokoyama, K.; Yamamoto, H.; Tokutome, G.; Hosoya, T. 2002: Effect of angiotensin II receptor antagonist (losartan) on renal function, serum potassium and blood pressure in patients with advanced renal failure: differences between patients with a serum creatinine (SCr) level higher than 3 mg/dl and those with a lower SCr level Nihon Jinzo Gakkai Shi 44(7): 530-536
Tacquet, A.; Devulder, B.; Cuvelier, D.; Legros, J. 1974: Pharmacokinetic aspects of thiamphenicol in subjects with normal renal function and in patients with chronic renal insufficiency, with or without haemodialysis Postgraduate Medical Journal 50(Suppl 5): 36-38
Degen, J.; Ringwelski, L.; Maier-Lenz, H. 1983: Concentration of cefadroxil in kidney tissue and serum after oral administration in patients with normal and impaired renal function Arzneimittel-Forschung 33(9): 1339-1342
Ng, C.Y.; Ghabrial, H.; Morgan, D.J.; Ching, M.S.; Smallwood, R.A.; Angus, P.W. 2000: Impaired elimination of propranolol due to right heart failure: drug clearance in the isolated liver and its relationship to intrinsic metabolic capacity Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(10): 1217-1221
Małecka, J.; Grzeszczak, W.; Zukowska-Szczechowska, E.; Jendryczko, A.; Baczyński, R. 1994: Levels of cadmium in serum of patients with chronic renal failure Przeglad Lekarski 51(7): 291-295
Vannucchi, M.T.; Vannucchi, H.; Humphreys, M. 1992: Serum levels of vitamin a and retinol binding protein in chronic renal patients treated by continuous ambulatorial peritoneal dialysis International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift für Vitamin- und Ernahrungsforschung. Journal International de Vitaminologie et de Nutrition 62(2): 107-112
Muolo, A.; Ghidini, O.; Tonon, M.; Galvani, E.; Baratta, P.F.; Confortini, P. 1976: Serum gastrin levels in patients with renal failure on maintenance haemodialysis and after successful kidney transplantation La Ricerca in Clinica e in Laboratorio 6(3): 277-284
McDiarmid, S.V.; Millis, M.; Terashita, G.; Ament, M.E.; Busuttil, R.; Terasaki, P. 1990: Low serum OKT3 levels correlate with failure to prevent rejection in orthotopic liver transplant patients Transplantation Proceedings 22(4): 1774-1776
Terekhov, N.T.; Kozyr', V.I. 1972: The excretory function of the liver in patients in the terminal stages of chronic renal failure Vrachebnoe Delo 6: 42-45
Burak, W.; Grzeszczak, W.; Trelewicz, P.; Zukowska-Szczechowska, E. 1996: The effect of hemodialysis on levels of beta-endorphin in serum of patients with chronic renal failure treated with erythropoietin Przeglad Lekarski 53(2): 54-57
Miura, Y. 1978: Serum transferrin levels in chronic renal failure. II. the relationship between anemia and nutrition in regular hemodialysis patients Nihon Jinzo Gakkai Shi 20(3): 243-253
Lewandowski, A.; Kozaczek, W.; Orlowski, T.; Weuta, H. 1986: Kidney function of pyelonephritis patients with impaired renal function treated with mezlocillin Arzneimittel-Forschung 36(7): 1148-1150
Szczepańska, M.; Szprynger, K.; Mazur, B.; Zwolińska, D.; Kiliś-Pstrusińska, K.; Makulska, I. 2007: Plasma ghrelin levels in children with chronic renal failure on peritoneal dialysis Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 27(1): 61-66
Pryzjemski, J.; Wlasiuk, M.; Chrostowska, H. 1976: Assessment of the gluconeogenetic function of the liver on the basis of blood lactate elimination in patients with acute and chronic liver damage Przeglad Lekarski 33(12): 979-983
Dolan, D.L.; Webb, C.E. 1985: Serum digoxin levels and renal failure North Carolina Medical Journal 46(9): 465-466
Feyko, J.; Hazard, H.; Cardinal, J.; Thomay, A.; Cho, S. 2016: Pancreatectomy in Patients with Impaired Renal Function: how Risky Is It? American Surgeon 82(1): 16-21